aluates Reports

$ 0.0

Automative

Global Graves Disease Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-29R5758

Global Graves Disease Market Insights Forecast to 2028

BUY CHAPTERS

Global Graves Disease Market Research Report 2025

Code: QYRE-Auto-29R5758

Report

June 2025

Pages:73

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Abbott Laboratories

GlaxoSmithKline PLC

Merck

Pfizer Inc

RLC Labs

AbbVie

Mylan N.V.

Allergan plc

Graves Disease Market

The global market for Graves Disease was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Graves’ disease is an autoimmune disorder that stimulates the thyroid gland to release excessive thyroid hormone, leading to hyperthyroidism. It is termed as Basedow’s disease in continental Europe and Graves’ disease in the U.S. In this disease, body’s immune system produces antibodies that help the thyroid gland to grow which in turn synthesizes abnormal levels of thyroid hormones causing hyperthyroidism.

North American market for Graves Disease is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Graves Disease is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Graves Disease in Hospital Pharmacy is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Graves Disease include Abbott Laboratories, GlaxoSmithKline plc, Merck & Co, Pfizer, Inc, RLC LABS, AbbVie, Inc, Mylan N.V, Allergan, plc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Graves Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Graves Disease.

The Graves Disease market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Graves Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Graves Disease companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Graves Disease Market Report

Report Metric	Details
Report Name	Graves Disease Market
Segment by Type	Anti-Thyroid Drugs Lodine &Lodides Radioactive Lodine Lonic Inhibitors
Segment by Application	Hospital Pharmacy Online Pharmacy Retail Pharmacy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott Laboratories, GlaxoSmithKline plc, Merck & Co, Pfizer, Inc, RLC LABS, AbbVie, Inc, Mylan N.V, Allergan, plc
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Graves Disease company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Graves Disease Market report?

Ans: The main players in the Graves Disease Market are Abbott Laboratories, GlaxoSmithKline plc, Merck & Co, Pfizer, Inc, RLC LABS, AbbVie, Inc, Mylan N.V, Allergan, plc

What are the Application segmentation covered in the Graves Disease Market report?

Ans: The Applications covered in the Graves Disease Market report are Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

What are the Type segmentation covered in the Graves Disease Market report?

Ans: The Types covered in the Graves Disease Market report are Anti-Thyroid Drugs, Lodine &Lodides, Radioactive Lodine, Lonic Inhibitors

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Graves Disease Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Anti-Thyroid Drugs

1.2.3 Lodine &Lodides

1.2.4 Radioactive Lodine

1.2.5 Lonic Inhibitors

1.3 Market by Application

1.3.1 Global Graves Disease Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacy

1.3.3 Online Pharmacy

1.3.4 Retail Pharmacy

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Graves Disease Market Perspective (2020-2031)

2.2 Global Graves Disease Growth Trends by Region

2.2.1 Global Graves Disease Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Graves Disease Historic Market Size by Region (2020-2025)

2.2.3 Graves Disease Forecasted Market Size by Region (2026-2031)

2.3 Graves Disease Market Dynamics

2.3.1 Graves Disease Industry Trends

2.3.2 Graves Disease Market Drivers

2.3.3 Graves Disease Market Challenges

2.3.4 Graves Disease Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Graves Disease Players by Revenue

3.1.1 Global Top Graves Disease Players by Revenue (2020-2025)

3.1.2 Global Graves Disease Revenue Market Share by Players (2020-2025)

3.2 Global Graves Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Graves Disease Revenue

3.4 Global Graves Disease Market Concentration Ratio

3.4.1 Global Graves Disease Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Graves Disease Revenue in 2024

3.5 Global Key Players of Graves Disease Head office and Area Served

3.6 Global Key Players of Graves Disease, Product and Application

3.7 Global Key Players of Graves Disease, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Graves Disease Breakdown Data by Type

4.1 Global Graves Disease Historic Market Size by Type (2020-2025)

4.2 Global Graves Disease Forecasted Market Size by Type (2026-2031)

5 Graves Disease Breakdown Data by Application

5.1 Global Graves Disease Historic Market Size by Application (2020-2025)

5.2 Global Graves Disease Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Graves Disease Market Size (2020-2031)

6.2 North America Graves Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Graves Disease Market Size by Country (2020-2025)

6.4 North America Graves Disease Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Graves Disease Market Size (2020-2031)

7.2 Europe Graves Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Graves Disease Market Size by Country (2020-2025)

7.4 Europe Graves Disease Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Graves Disease Market Size (2020-2031)

8.2 Asia-Pacific Graves Disease Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Graves Disease Market Size by Region (2020-2025)

8.4 Asia-Pacific Graves Disease Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Graves Disease Market Size (2020-2031)

9.2 Latin America Graves Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Graves Disease Market Size by Country (2020-2025)

9.4 Latin America Graves Disease Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Graves Disease Market Size (2020-2031)

10.2 Middle East & Africa Graves Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Graves Disease Market Size by Country (2020-2025)

10.4 Middle East & Africa Graves Disease Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott Laboratories

11.1.1 Abbott Laboratories Company Details

11.1.2 Abbott Laboratories Business Overview

11.1.3 Abbott Laboratories Graves Disease Introduction

11.1.4 Abbott Laboratories Revenue in Graves Disease Business (2020-2025)

11.1.5 Abbott Laboratories Recent Development

11.2 GlaxoSmithKline plc

11.2.1 GlaxoSmithKline plc Company Details

11.2.2 GlaxoSmithKline plc Business Overview

11.2.3 GlaxoSmithKline plc Graves Disease Introduction

11.2.4 GlaxoSmithKline plc Revenue in Graves Disease Business (2020-2025)

11.2.5 GlaxoSmithKline plc Recent Development

11.3 Merck & Co

11.3.1 Merck & Co Company Details

11.3.2 Merck & Co Business Overview

11.3.3 Merck & Co Graves Disease Introduction

11.3.4 Merck & Co Revenue in Graves Disease Business (2020-2025)

11.3.5 Merck & Co Recent Development

11.4 Pfizer, Inc

11.4.1 Pfizer, Inc Company Details

11.4.2 Pfizer, Inc Business Overview

11.4.3 Pfizer, Inc Graves Disease Introduction

11.4.4 Pfizer, Inc Revenue in Graves Disease Business (2020-2025)

11.4.5 Pfizer, Inc Recent Development

11.5 RLC LABS

11.5.1 RLC LABS Company Details

11.5.2 RLC LABS Business Overview

11.5.3 RLC LABS Graves Disease Introduction

11.5.4 RLC LABS Revenue in Graves Disease Business (2020-2025)

11.5.5 RLC LABS Recent Development

11.6 AbbVie, Inc

11.6.1 AbbVie, Inc Company Details

11.6.2 AbbVie, Inc Business Overview

11.6.3 AbbVie, Inc Graves Disease Introduction

11.6.4 AbbVie, Inc Revenue in Graves Disease Business (2020-2025)

11.6.5 AbbVie, Inc Recent Development

11.7 Mylan N.V

11.7.1 Mylan N.V Company Details

11.7.2 Mylan N.V Business Overview

11.7.3 Mylan N.V Graves Disease Introduction

11.7.4 Mylan N.V Revenue in Graves Disease Business (2020-2025)

11.7.5 Mylan N.V Recent Development

11.8 Allergan, plc

11.8.1 Allergan, plc Company Details

11.8.2 Allergan, plc Business Overview

11.8.3 Allergan, plc Graves Disease Introduction

11.8.4 Allergan, plc Revenue in Graves Disease Business (2020-2025)

11.8.5 Allergan, plc Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Abbott Laboratories

GlaxoSmithKline PLC

Merck

Pfizer Inc

RLC Labs

AbbVie

Mylan N.V.

Allergan plc

List of Tables

Table 1. Global Graves Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Anti-Thyroid Drugs

Table 3. Key Players of Lodine &Lodides

Table 4. Key Players of Radioactive Lodine

Table 5. Key Players of Lonic Inhibitors

Table 6. Global Graves Disease Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Graves Disease Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Graves Disease Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Graves Disease Market Share by Region (2020-2025)

Table 10. Global Graves Disease Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Graves Disease Market Share by Region (2026-2031)

Table 12. Graves Disease Market Trends

Table 13. Graves Disease Market Drivers

Table 14. Graves Disease Market Challenges

Table 15. Graves Disease Market Restraints

Table 16. Global Graves Disease Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Graves Disease Market Share by Players (2020-2025)

Table 18. Global Top Graves Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Graves Disease as of 2024)

Table 19. Ranking of Global Top Graves Disease Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Graves Disease Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Graves Disease, Headquarters and Area Served

Table 22. Global Key Players of Graves Disease, Product and Application

Table 23. Global Key Players of Graves Disease, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Graves Disease Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Graves Disease Revenue Market Share by Type (2020-2025)

Table 27. Global Graves Disease Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Graves Disease Revenue Market Share by Type (2026-2031)

Table 29. Global Graves Disease Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Graves Disease Revenue Market Share by Application (2020-2025)

Table 31. Global Graves Disease Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Graves Disease Revenue Market Share by Application (2026-2031)

Table 33. North America Graves Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Graves Disease Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Graves Disease Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Graves Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Graves Disease Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Graves Disease Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Graves Disease Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Graves Disease Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Graves Disease Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Graves Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Graves Disease Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Graves Disease Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Graves Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Graves Disease Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Graves Disease Market Size by Country (2026-2031) & (US$ Million)

Table 48. Abbott Laboratories Company Details

Table 49. Abbott Laboratories Business Overview

Table 50. Abbott Laboratories Graves Disease Product

Table 51. Abbott Laboratories Revenue in Graves Disease Business (2020-2025) & (US$ Million)

Table 52. Abbott Laboratories Recent Development

Table 53. GlaxoSmithKline plc Company Details

Table 54. GlaxoSmithKline plc Business Overview

Table 55. GlaxoSmithKline plc Graves Disease Product

Table 56. GlaxoSmithKline plc Revenue in Graves Disease Business (2020-2025) & (US$ Million)

Table 57. GlaxoSmithKline plc Recent Development

Table 58. Merck & Co Company Details

Table 59. Merck & Co Business Overview

Table 60. Merck & Co Graves Disease Product

Table 61. Merck & Co Revenue in Graves Disease Business (2020-2025) & (US$ Million)

Table 62. Merck & Co Recent Development

Table 63. Pfizer, Inc Company Details

Table 64. Pfizer, Inc Business Overview

Table 65. Pfizer, Inc Graves Disease Product

Table 66. Pfizer, Inc Revenue in Graves Disease Business (2020-2025) & (US$ Million)

Table 67. Pfizer, Inc Recent Development

Table 68. RLC LABS Company Details

Table 69. RLC LABS Business Overview

Table 70. RLC LABS Graves Disease Product

Table 71. RLC LABS Revenue in Graves Disease Business (2020-2025) & (US$ Million)

Table 72. RLC LABS Recent Development

Table 73. AbbVie, Inc Company Details

Table 74. AbbVie, Inc Business Overview

Table 75. AbbVie, Inc Graves Disease Product

Table 76. AbbVie, Inc Revenue in Graves Disease Business (2020-2025) & (US$ Million)

Table 77. AbbVie, Inc Recent Development

Table 78. Mylan N.V Company Details

Table 79. Mylan N.V Business Overview

Table 80. Mylan N.V Graves Disease Product

Table 81. Mylan N.V Revenue in Graves Disease Business (2020-2025) & (US$ Million)

Table 82. Mylan N.V Recent Development

Table 83. Allergan, plc Company Details

Table 84. Allergan, plc Business Overview

Table 85. Allergan, plc Graves Disease Product

Table 86. Allergan, plc Revenue in Graves Disease Business (2020-2025) & (US$ Million)

Table 87. Allergan, plc Recent Development

Table 88. Research Programs/Design for This Report

Table 89. Key Data Information from Secondary Sources

Table 90. Key Data Information from Primary Sources

Table 91. Authors List of This Report

List of Figures

Figure 1. Graves Disease Picture

Figure 2. Global Graves Disease Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Graves Disease Market Share by Type: 2024 VS 2031

Figure 4. Anti-Thyroid Drugs Features

Figure 5. Lodine &Lodides Features

Figure 6. Radioactive Lodine Features

Figure 7. Lonic Inhibitors Features

Figure 8. Global Graves Disease Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Graves Disease Market Share by Application: 2024 VS 2031

Figure 10. Hospital Pharmacy Case Studies

Figure 11. Online Pharmacy Case Studies

Figure 12. Retail Pharmacy Case Studies

Figure 13. Graves Disease Report Years Considered

Figure 14. Global Graves Disease Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Graves Disease Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Graves Disease Market Share by Region: 2024 VS 2031

Figure 17. Global Graves Disease Market Share by Players in 2024

Figure 18. Global Top Graves Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Graves Disease as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Graves Disease Revenue in 2024

Figure 20. North America Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Graves Disease Market Share by Country (2020-2031)

Figure 22. United States Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Graves Disease Market Share by Country (2020-2031)

Figure 26. Germany Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Graves Disease Market Share by Region (2020-2031)

Figure 34. China Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Graves Disease Market Share by Country (2020-2031)

Figure 42. Mexico Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Graves Disease Market Share by Country (2020-2031)

Figure 46. Turkey Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Graves Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Abbott Laboratories Revenue Growth Rate in Graves Disease Business (2020-2025)

Figure 50. GlaxoSmithKline plc Revenue Growth Rate in Graves Disease Business (2020-2025)

Figure 51. Merck & Co Revenue Growth Rate in Graves Disease Business (2020-2025)

Figure 52. Pfizer, Inc Revenue Growth Rate in Graves Disease Business (2020-2025)

Figure 53. RLC LABS Revenue Growth Rate in Graves Disease Business (2020-2025)

Figure 54. AbbVie, Inc Revenue Growth Rate in Graves Disease Business (2020-2025)

Figure 55. Mylan N.V Revenue Growth Rate in Graves Disease Business (2020-2025)

Figure 56. Allergan, plc Revenue Growth Rate in Graves Disease Business (2020-2025)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Thyroid Eye Disease Treatments Market Research Report 2024

Global Autoimmune Thyroid Assays Market Research Report 2024

Global Hashimotos Thyroiditis Drug Market Insights Forecast to 2030

Thyroid Disorder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hyperthyroidism Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hyperthyroidism Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Thyroid Eye Treatment Market Research Report 2025

Antithyroid Medications for Hyperthyroidism Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Autoimmune Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hypothyroidism Drugs Market Insights Forecast to 2030

Global Thyroid Gland Disorders Treatment Market Research Report 2025

Hypothyroidism Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Autoimmune Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Silent Thyroiditis Market Research Report 2024

Underactive Thyroid Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Autoimmunity Reagents Market Research Report 2024

Global Methimazole Tablets Market Research Report 2024

Global Antithyroid Preparations Market Research Report 2024

Global Antithyroid Drug Market Research Report 2024

RELATED REPORTS

Global Insulin Coolers Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19Z7671

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Ossicular Prostheses Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10V14317

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Defibrillator Accessories Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10O5919

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Septicemia Diagnostic Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4I19963

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions